What is the most effective treatment for PCOS?

PCOS has no cure, and treatment is personalised to the individual's primary concerns. For most women, lifestyle modification — particularly improving diet quality and increasing physical activity — is the most broadly effective first step, especially with any degree of overweight or insulin resistance. Specific medications (metformin, the combined pill, anti-androgens, ovulation induction agents) are added based on the predominant symptoms: metabolic, hormonal, or fertility-related.

How much weight loss is needed to see improvement in PCOS?

In women with overweight or obesity, modest weight loss of as little as 5–10% of body weight meaningfully improves insulin sensitivity, reduces androgen levels, restores ovulatory cycles, improves acne and hirsutism, and enhances fertility. The weight loss does not need to reach any particular target — small reductions produce measurable hormonal and metabolic benefits. For women at a healthy weight, the focus is on diet quality and activity rather than weight reduction.

Does exercise help PCOS even without weight loss?

Yes. Exercise improves insulin sensitivity independently of weight change. Regular aerobic exercise reduces fasting insulin and androgen levels, improves menstrual regularity, and supports mental health and metabolic risk reduction even without significant weight loss. Resistance training also improves body composition and insulin sensitivity in PCOS.

Is metformin safe to take long-term for PCOS?

Metformin has a strong long-term safety record and is widely used in people with insulin resistance and type 2 diabetes. In women with PCOS, it can be used long-term for metabolic management, menstrual regulation, or as an ongoing measure to reduce diabetes risk. Monitoring for side effects (predominantly gastrointestinal) and checking B12 levels annually (as metformin can reduce B12 absorption over time) is recommended.

Can PCOS be managed without medication?

For many women, particularly those with mild-to-moderate symptoms, lifestyle modification alone produces meaningful improvement. However, some aspects of PCOS — particularly significant insulin resistance, fertility concerns, or severe hyperandrogenic symptoms — often benefit from medication alongside lifestyle changes. The decision about medication should be made with your doctor, weighing your specific symptoms and goals.

How does PCOS affect mental health?

PCOS is associated with significantly elevated rates of depression and anxiety — roughly twice the prevalence in age-matched women without PCOS. This is partly driven by visible symptoms (hair changes, weight, skin), the burden of a chronic diagnosis, and fertility concerns, but there are likely also independent biological pathways involving insulin resistance and androgens. Mental health should be routinely assessed and addressed as part of PCOS care.

PCOS Management: Lifestyle, Medications, and Long-Term Care

Managing PCOS: A Practical Guide

PCOS is a lifelong condition with no cure — but it is highly manageable. Effective management reduces symptoms, protects long-term metabolic and cardiovascular health, improves fertility outcomes for women seeking pregnancy, and supports psychological wellbeing.

Management is always personalised: what works best depends on current symptoms, goals (contraception, fertility, skin, metabolic health), weight, and individual health history.

This guide is a companion to PCOS: Understanding Polycystic Ovary Syndrome, which covers diagnosis, the Rotterdam criteria, and the underlying biology.

Key Points

Lifestyle modification — particularly diet quality and physical activity — is first-line for most women with PCOS.
Even 5–10% weight loss in overweight women produces significant hormonal and metabolic improvement.
Exercise improves insulin sensitivity independently of weight loss.
Metformin is safe long-term and reduces the risk of progression to type 2 diabetes.
Treatment of symptoms (acne, hirsutism, irregular cycles) is targeted and personalised.
Mental health is an integral part of PCOS management — not an afterthought.
Long-term monitoring for cardiovascular and metabolic risk remains important after the reproductive years.

Lifestyle: The Foundation

Weight Management

For women with PCOS and overweight or obesity, weight loss is among the most effective interventions available. Studies consistently show that 5–10% reduction in body weight produces:

Improved insulin sensitivity
Reduced circulating androgens
Restoration or regularisation of menstrual cycles
Improvement in acne and hirsutism
Enhanced fertility and ovulation induction response
Better lipid profiles and blood pressure

Weight management does not require reaching a target BMI — smaller reductions produce meaningful change.

Approach:

A moderate caloric deficit (500 kcal/day below estimated needs) is achievable and sustainable
Diet quality matters as much as quantity
Avoid extreme restriction, which can worsen hormonal disruption and increase physiological stress
Supported weight management programmes improve outcomes compared with self-guided attempts

For women at a healthy weight with PCOS, the focus shifts to diet quality and physical activity rather than weight reduction.

Exercise

Regular physical activity is independently beneficial in PCOS — not just as a weight management tool:

Aerobic exercise (brisk walking, cycling, swimming) — improves insulin sensitivity, reduces fasting insulin, supports cardiovascular health; aim for at least 150 minutes per week of moderate-intensity activity
Resistance training — improves body composition, insulin sensitivity, and androgen profiles independently of aerobic exercise; 2–3 sessions per week
Combined programmes — aerobic plus resistance training produces superior outcomes compared with either alone in PCOS trials

Exercise also has significant benefits for mental health in PCOS, reducing anxiety and depression and improving body image.

Nutrition

No single diet has been proven superior for PCOS, but the evidence points toward several consistent principles:

Dietary approach	Evidence in PCOS
Low glycaemic index (GI) diet	Reduces insulin levels, improves menstrual regularity, supports weight management
Mediterranean-style diet	Reduces inflammation, improves metabolic markers, strong cardiovascular evidence
High-protein diets	Support satiety and may improve insulin response
Very low carbohydrate / ketogenic	Short-term weight loss and insulin improvements; long-term sustainability uncertain

Practical principles:

Prioritise whole foods, vegetables, legumes, lean proteins, and healthy fats
Choose lower-GI carbohydrates (wholegrains, legumes, oats) over refined starches and added sugar
Reduce ultra-processed food intake
Maintain regular meals — skipping meals worsens insulin dynamics
Moderate alcohol — alcohol worsens insulin resistance and inflammation

Medications

Metformin

Metformin is the most commonly prescribed medication for metabolic management of PCOS. It:

Reduces hepatic glucose production and improves peripheral insulin sensitivity
Lowers circulating androgen levels
May restore or regularise menstrual cycles
Reduces the risk of progression to type 2 diabetes
Improves response to ovulation induction when used alongside letrozole or clomiphene
Has modest effects on weight (typically 1–3 kg reduction over 6 months)

Who benefits most: Women with significant insulin resistance, elevated fasting glucose or HbA1c, or those pursuing ovulation induction.

Practical note: Start at a low dose (500 mg with meals) and titrate slowly to reduce gastrointestinal side effects (nausea, diarrhoea). Extended-release formulations are better tolerated by many women.

Long-term monitoring: Check B12 annually — metformin can impair B12 absorption over time.

Combined Oral Contraceptive Pill (OCP)

For women not seeking pregnancy, the combined OCP is the cornerstone of symptom management for:

Menstrual regulation — provides predictable withdrawal bleeds, protecting the endometrium
Hirsutism and acne — suppresses LH-driven ovarian androgen production; increases SHBG, reducing free testosterone
Endometrial protection — prevents endometrial hyperplasia from chronic anovulation

Anti-androgenic progestogens (drospirenone, cyproterone acetate) are preferred for significant hirsutism or acne. Standard preparations are effective for cycle regulation.

Important: The OCP suppresses symptoms but does not treat the underlying PCOS. Symptoms typically return on discontinuation.

Anti-Androgens

Used when hirsutism, acne, or androgenic alopecia is the primary concern:

Spironolactone (50–200 mg/day) — reduces hirsutism and acne; safe and well tolerated; requires reliable contraception (teratogenic in pregnancy)
Cyproterone acetate — potent anti-androgen, often combined with oestrogen; used for severe hyperandrogenic symptoms
Finasteride — blocks dihydrotestosterone (DHT); used for androgenic alopecia; requires contraception

Effects on hirsutism take 6–12 months to become apparent — hair follicles cycle slowly.

GLP-1 Receptor Agonists

For women with PCOS and significant obesity or type 2 diabetes, GLP-1 receptor agonists (e.g. semaglutide, liraglutide) are increasingly used:

Produce substantial weight loss (10–15% with semaglutide in clinical trials)
Improve insulin sensitivity and androgen profiles
May restore menstrual regularity
Growing evidence in PCOS specifically

Currently considered where lifestyle changes and metformin have been insufficient.

Fertility and PCOS

PCOS is a leading cause of anovulatory infertility, but most women with PCOS who seek pregnancy can conceive. The pathway depends on cycle regularity and prior investigations.

Step 1: Lifestyle Modification

For overweight women, 5–10% weight loss often restores ovulation without medication. This is the most cost-effective first step and is recommended before pharmacological ovulation induction in eligible women.

Step 2: Ovulation Induction

First-line medical treatment for PCOS-related infertility:

Letrozole (2.5–7.5 mg/day, days 3–7 of cycle) — now the preferred first-line agent; superior live birth rates and lower multiple pregnancy risk compared with clomiphene in PCOS
Clomiphene citrate — established option; still widely used; clomiphene resistance occurs in up to 25% of women with PCOS
Metformin — often added to letrozole; improves ovulatory response, particularly in insulin-resistant women

Step 3: Further Options

Laparoscopic ovarian drilling — surgical disruption of ovarian androgen-producing tissue; restores ovulation in approximately 50–80% of clomiphene-resistant women; avoids multiple pregnancy risk
IVF — for complex cases or failed ovulation induction; women with PCOS face elevated risk of ovarian hyperstimulation syndrome (OHSS), requiring careful stimulation protocols

When to Refer to a Fertility Specialist

No conception after 6 months of ovulation induction with regular cycles
Both partners require investigation
Age 35 or over with no conception after 3–4 cycles
Additional infertility factors (tubal, male factor)

Mental Health in PCOS

Mental health is integral to PCOS management — not an optional extra. Women with PCOS have:

Approximately twice the risk of depression compared with women without PCOS
Significantly elevated rates of anxiety
Higher rates of disordered eating and body dysmorphia
Reduced quality of life not always correlated with symptom severity

Contributing factors include:

Visible symptoms (excess hair, acne, weight gain, hair loss) affecting body image
The psychological burden of a complex chronic diagnosis
Fertility anxiety
Possible independent biological pathways (insulin resistance, inflammation, androgen effects)

Management should include:

Routine screening for depression and anxiety at diagnosis and follow-up appointments
Psychological therapies (CBT, ACT) — effective for PCOS-related mental health
Explicit acknowledgement of body image concerns — they are not trivial
Peer support (PCOS organisations, online communities) — meaningful benefit for many women
Physical activity — strong evidence for mental health improvement in PCOS specifically

Long-Term Monitoring

PCOS is not only a reproductive condition. The metabolic and cardiovascular risks require ongoing attention across the lifespan.

Test	Frequency	Why
Blood glucose / HbA1c	Every 1–2 years	3–7× type 2 diabetes risk
Lipid profile	Every 2–5 years (more frequently if abnormal)	Dyslipidaemia is common
Blood pressure	Every clinical visit	Elevated hypertension risk
Mental health screen	Annually	Elevated depression/anxiety rates
Endometrial assessment	If no period for >3–6 months	Endometrial hyperplasia risk with prolonged anovulation

After the reproductive years, metabolic and cardiovascular risks remain elevated — and may worsen at menopause as oestrogen decline adds to existing insulin resistance and dyslipidaemia. Monitoring does not stop with the end of the reproductive years.

Educational only; not a substitute for professional medical advice.